SBTX Penny Biopharma on ROUNDED BOTTOM REVERSAL - Daily Chart

NASDAQ:SBTX   Silverback Therapeutics, Inc


with upcoming earnings
chart shows

The potential red flag is the company seems to be
setting up for a merger at the end of the year
and a press release suggests that the only product
will be a decongestant nose spray ( Niffy)
with a new ticker SPRY

So the question is trade off the curent techicals
but pay heed to fundamentals and upcoming guidance
from earnings ? What is your opinion ?

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.